Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Learn the scenarios where index funds outperform target date funds, with emphasis on fees, control, and asset allocation flexibility.
26,348 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Wingstop has slumped 60% in the last year amid a negative equity balance sheet. Meanwhile, three asset-heavy stocks—r...
When a family trusted a dealer to grade their Pokémon cards, they didn't just lose cards—they risked financial ruin. ...
A reporter documenting a geopolitics-driven forecast market linked to a $14 million pool received direct threats, pro...
Occidental Petroleum leads the 2026 performance among three top U.S. energy explorers, with EOG Resources and ConocoP...
Insider trades by top executives can shape market perception. This guide explains what a chief medical officer sells ...
Prediction markets offer a different lens on big corporate moves. Discover what kalshi traders chance spacex says abo...
U.S. stocks surged, with the S&P 500 hitting a fresh peak and a new company joining the $1 trillion market-cap circle...
With the Social Security trust fund projected to run dry by the early 2030s, Congress faces a high-stakes fight over ...
Cardano is facing a challenging period. In this guide, you’ll learn how to assess whether the cardano crisis signals ...
Private equity is moving from wall street legends to the everyday investor. Here’s how cathie wood's private equity i...
An executive stock sale can signal many things. This article breaks down the numbers, the reporting rules, and practi...